BG106961A - Phenylpiperazinyl derivatives - Google Patents

Phenylpiperazinyl derivatives

Info

Publication number
BG106961A
BG106961A BG106961A BG10696102A BG106961A BG 106961 A BG106961 A BG 106961A BG 106961 A BG106961 A BG 106961A BG 10696102 A BG10696102 A BG 10696102A BG 106961 A BG106961 A BG 106961A
Authority
BG
Bulgaria
Prior art keywords
derivatives
phenylpiperazinyl derivatives
phenylpiperazinyl
alk
dopamine
Prior art date
Application number
BG106961A
Other languages
Bulgarian (bg)
English (en)
Inventor
Thomas Ruhland
Jan Kehler
Kim Andersen
Benny Bang-Andersen
Mario Rottlaender
Original Assignee
H.Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H.Lundbeck A/S filed Critical H.Lundbeck A/S
Publication of BG106961A publication Critical patent/BG106961A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
BG106961A 1999-12-30 2002-07-26 Phenylpiperazinyl derivatives BG106961A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901886 1999-12-30
PCT/DK2000/000720 WO2001049677A1 (en) 1999-12-30 2000-12-20 Phenylpiperazinyl derivatives

Publications (1)

Publication Number Publication Date
BG106961A true BG106961A (en) 2003-04-30

Family

ID=8108810

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106961A BG106961A (en) 1999-12-30 2002-07-26 Phenylpiperazinyl derivatives

Country Status (24)

Country Link
US (1) US20030083336A1 (es)
EP (1) EP1246815B1 (es)
JP (1) JP2003519223A (es)
KR (1) KR20020067589A (es)
CN (1) CN1437596A (es)
AR (1) AR029217A1 (es)
AT (1) ATE261958T1 (es)
AU (1) AU2152001A (es)
BG (1) BG106961A (es)
BR (1) BR0016951A (es)
CA (1) CA2395867A1 (es)
DE (1) DE60009154D1 (es)
EA (1) EA200200731A1 (es)
HU (1) HUP0203645A3 (es)
IL (1) IL150337A0 (es)
IS (1) IS6431A (es)
MX (1) MXPA02006499A (es)
NO (1) NO20023149D0 (es)
NZ (1) NZ519692A (es)
PL (1) PL355540A1 (es)
SK (1) SK11062002A3 (es)
TR (1) TR200201684T2 (es)
WO (1) WO2001049677A1 (es)
ZA (1) ZA200204970B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040002488A1 (en) * 2002-05-29 2004-01-01 Cowart Marlon D. Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
EP1927594A1 (en) * 2003-01-14 2008-06-04 Arena Pharmaceuticals, Inc. 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
US8293751B2 (en) * 2003-01-14 2012-10-23 Arena Pharmaceuticals, Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
RS50589B (sr) 2003-12-23 2010-05-07 H. Lundbeck A/S. 2-(1h-indolilsulfanil)-benzil amin derivati kao ssri
AR052308A1 (es) 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
NZ555491A (en) * 2005-01-03 2010-01-29 Univ Siena Aryl piperazine derivatives for the treatment of neuropsychiatric disorders
US7629473B2 (en) 2005-06-17 2009-12-08 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-aryl amine derivatives
KR100868353B1 (ko) * 2007-03-08 2008-11-12 한국화학연구원 도파민 d4 수용체 길항제인 신규 피페라지닐프로필피라졸유도체, 이의 제조방법 및 이를 포함하는 약학적 조성물
BR112013008100A2 (pt) 2010-09-22 2016-08-09 Arena Pharm Inc "moduladores do receptor de gpr19 e o tratamento de distúrbios relacionados a eles."
CN104725359B (zh) 2013-12-20 2017-05-03 广东东阳光药业有限公司 取代的哌嗪化合物及其使用方法和用途
CN105085482B (zh) * 2014-05-04 2018-08-10 广东东阳光药业有限公司 取代的哌嗪化合物及其使用方法和用途
CN105085491B (zh) * 2014-05-05 2019-06-25 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
GB201416352D0 (en) 2014-09-16 2014-10-29 Shire Internat Gmbh Spirocyclic derivatives
GB201416351D0 (en) * 2014-09-16 2014-10-29 Shire Internat Gmbh Heterocyclic derivatives
CN105732591B (zh) * 2014-12-31 2019-10-25 广东东阳光药业有限公司 取代的哌嗪化合物及其使用方法和用途
CN116850181A (zh) 2015-01-06 2023-10-10 艾尼纳制药公司 治疗与s1p1受体有关的病症的方法
MX2017016530A (es) 2015-06-22 2018-03-12 Arena Pharm Inc Sal cristalina de l-arginina del acido (r)-2-(7-(4-ciclopentil-3-( trifluorometil)benciloxi)-1,2,3,4-tetrahidrociclopenta[b]indol-3- il)acetico (compuesto1) para ser utilizada en transtornos asociados con el receptor de esfingosina-1-fosfato 1 (s1p1).
CN106795160B (zh) * 2015-07-23 2019-04-19 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
CN106795143B (zh) * 2015-08-13 2019-05-24 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
CN110520124A (zh) 2017-02-16 2019-11-29 艾尼纳制药公司 用于治疗原发性胆汁性胆管炎的化合物和方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
GB9305623D0 (en) * 1993-03-18 1993-05-05 Merck Sharp & Dohme Therapeutic agents
GB9306578D0 (en) * 1993-03-30 1993-05-26 Merck Sharp & Dohme Therapeutic agents
US5814644A (en) * 1993-04-15 1998-09-29 Merck Sharp & Dohme, Ltd. Indole derivatives as dopamine D4 antagonists
WO1995029911A1 (en) * 1994-04-28 1995-11-09 Merck Sharp & Dohme Limited Benzofuran derivatives as d4 receptor antagonists
ES2201105T3 (es) * 1994-08-05 2004-03-16 Pfizer Inc. Derivados del bencimidazol con actividad dopaminergica.
USH2007H1 (en) * 1996-01-19 2001-12-04 Fmc Corporation Insecticidal N-heterocyclylalkyl-or N-[(polycyclyl)alkyl]-N′substituted piperazines

Also Published As

Publication number Publication date
IL150337A0 (en) 2002-12-01
CN1437596A (zh) 2003-08-20
IS6431A (is) 2002-06-19
EP1246815B1 (en) 2004-03-17
AU2152001A (en) 2001-07-16
EA200200731A1 (ru) 2002-12-26
HUP0203645A2 (hu) 2003-02-28
JP2003519223A (ja) 2003-06-17
DE60009154D1 (de) 2004-04-22
AR029217A1 (es) 2003-06-18
PL355540A1 (en) 2004-05-04
ZA200204970B (en) 2004-01-26
MXPA02006499A (es) 2002-11-29
EP1246815A1 (en) 2002-10-09
KR20020067589A (ko) 2002-08-22
NO20023149L (no) 2002-06-28
SK11062002A3 (sk) 2002-12-03
TR200201684T2 (tr) 2002-10-21
BR0016951A (pt) 2003-02-25
ATE261958T1 (de) 2004-04-15
WO2001049677A1 (en) 2001-07-12
US20030083336A1 (en) 2003-05-01
HUP0203645A3 (en) 2004-01-28
NO20023149D0 (no) 2002-06-28
NZ519692A (en) 2004-05-28
CA2395867A1 (en) 2001-07-12

Similar Documents

Publication Publication Date Title
BG106961A (en) Phenylpiperazinyl derivatives
NZ519241A (en) Tricyclic fused heterocyclic compound, process for preparing it and medicament comprising it
MY136270A (en) Processes and intermediates for preparing anti-cancer compounds
MY132671A (en) Substituted 6,6-hetero-bicyclic derivatives
BG106933A (en) Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
MY118498A (en) Lactam derivatives
AU2029497A (en) Piperazine and piperidine compounds
CA2381819A1 (en) New benzimidazolone derivatives having mixed serotonine and dopamine receptors affinity
YU78303A (sh) Postupak za dobijanje 1,3-supstituisanih indena i azapolicikličnih jedinjenja sa pripojenim arilom
MY138826A (en) 2,7-substituted indoles
BG104447A (en) Biphenylamidine derivatives
BG105710A (en) 5ht1 antagonists for antidepressant therapy
YU1302A (sh) Derivati aminotiazola i njihova primena kao liganada crf receptora
MXPA05010651A (es) Compuestos de pirazol.
BG106937A (en) Novel indole derivatives
WO1999021848A3 (en) Novel 1-(n'-(arylalkylaminoalkyl))aminoisoindoles; a new class of dopamine receptor subtype specific ligands
MX9603199A (es) Antagonistas de receptores a endotelina.
BG106117A (en) Novel 8a- and 9a-15-membered lactams
GB2341799B (en) Medicaments for the treatment of primary headache disorders and drug-induced headaches
MY139258A (en) Carbamoyl-type benzofuran derivatives
AP2002002595A0 (en) Heterocyclic amide derivatives.
AU3648093A (en) Pyrrolidine derivatives useful as 5-HT3-antagonists
BG105247A (en) N-substituted azabicycloheptane derivatives, production and use thereof
RS47004A (en) Hexacyclic compounds
BG106281A (en) New 2,3-benzodiazepine derivatives